GSK-3 antibody | knockout validation | Santa Cruz sc-9166
DOI
//dx.doi.org/10.13070/ko.en.6.1877
Date
2016-11-30

This is a knockout-validated antibody summary, based on the publication "Tumour suppressor TRIM33 targets nuclear β-catenin degradation", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit polyclonal IgG

Company: Santa Cruz

Antibody: GSK-3

Catalog number: sc-9166

Summary: Rabbit polyclonal IgG against an epitope corresponding to amino acids 345-420 mapping at the C-terminus of human GSK-3β. Recommended for detection of GSK-3β of human, mouse, and rat by western blot, immunoprecipitation, immunofluorescence, immunohistochemistry (paraffin) and ELISA. Also reactive with additional species, including equine, canine, bovine, porcine and avian.

Validation Method

Western blot

Sample

Nuclear extracts from GSK-3β−/− MEFs.

Primary incubation

1:1,000 dilution.

Notes

Validation has no positive control.

Figure

Please see Figure 3a in the article [1].

Disclaimer

If the antibody described in this summary is a polyclonal antibody, since polyclonal antibodies are of limited quantity, please inquire the supplier whether any current polyclonal antibody with the same catalog number is exactly the same as the one described in this summary. Sometimes, different bleeds or different animals are used, usually with a different lot number. In such cases, the result in this summary may not apply to the new antibody with the same catalog number.

References
  1. Xue J, Chen Y, Wu Y, Wang Z, Zhou A, Zhang S, et al. Tumour suppressor TRIM33 targets nuclear β-catenin degradation. Nat Commun. 2015;6:6156 pubmed publisher